...
首页> 外文期刊>International journal of oncology >MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro
【24h】

MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro

机译:MicroRNA-34a体外调节头颈部鳞状细胞癌的上皮-间质转化和癌症干细胞表型

获取原文

摘要

MicroRNAs (miRs) are short non-coding single stranded RNAs regulating the translation of target mRNAs in normal and cancer cells in which they are frequently dysregulated promoting tumor progression. Cancer stem cells (CSCs) of head and neck squamous cell carcinoma (HNSCC), identified by aldehyde-dehydrogenase expression (ALDH), are a cell subset within the tumor cell population that takes part in the genesis and progression of cancer. The relevance of epithelial-mesenchymal transition (EMT) has recently been recognized for tumor development and metastasis. Several studies have illustrated that miRs regulate EMT of CSC. CSC from 8 HNSCC lines, 4 of which are human papillomavirus (HPV)?positive, were enriched by spheroid culture (spheroid-derived cells, SDC) and compared to their parental monolayer-derived cells (MDC) to analyze expression patterns of miR?34a, CSC-related transcription factors (CSC-TFs: Sox2, Nanog, Oct3/4) and EMT-related TFs (EMT-TFs: Twist, Snail1, Snail2) by RT-qPCR. Flow cytometry was used to quantify and enrich ALDH+ CSCs. Transfection of miR?34a mimics was used to evaluate its regulatory potential for CSC marker profiles as well as CSC- and EMT-TFs expression in HNSCC-SDC. Invasive, colony-forming and clonogenic capability of the miR?34a mimics transfected SDC after sorting for ALDH+ and ALDH- cells was assessed by Matrigel invasion, clonogenicity and spheroid formation assay, respectively. miR?34a expression levels were significantly downregulated in the majority of SDC derived from HNSCC-lines as compared to parental MDC (-1.6-16.4-fold). For EMT- and CSC-related TF expression, all HNSCC-derived SDC showed a significantly increased level compared to parental MDC (≤36.8-fold). Significantly increased expression of ALDH was found in SDC (2-3-fold). Compared to the HPV+, the HPV- group showed a significantly higher mean expression level of EMT-TFs, CSCs-TFs and ALDH (30.3 v.s. 12.8%). Transfection of miR?34a mimics significantly reduced the EMT- and CSC-related TF expression level in UM-SCC9 (HPV-) and UM-SCC47 (HPV+) SDC. Simultaneously, the ALDH expression was reduced significantly (1.5-2-fold) and the invasive capacity (≤30%) and clonogenicity of HNSCC-SDC was also inhibited by transfection of miR?34a mimics compared to controls. Restoration of miR?34a significantly inhibited the capability for EMT formation of CSC-phenotype and functionally reduced clonogenic and invasive capacity in HNSCC cell lines. Therapeutic modulation of miR?34a in HNSCC and CSCs may reduce the rate of metastasis and recurrence of tumors after therapy.
机译:MicroRNA(miRs)是短链非编码单链RNA,可调节正常细胞和癌细胞中靶mRNA的翻译,在这些细胞中,它们经常失调促进肿瘤进展。通过醛脱氢酶表达(ALDH)鉴定的头颈部鳞状细胞癌(HNSCC)癌干细胞(CSC)是肿瘤细胞群中的一个细胞亚群,参与癌症的发生和发展。最近已经认识到上皮-间质转化(EMT)的相关性与肿瘤的发展和转移。多项研究表明,miR调节CSC的EMT。来自8个HNSCC系的CSC通过球体培养(球体来源的细胞,SDC)富集,并与它们的亲代单层来源的细胞(MDC)进行了比较,以分析miR?的表达模式。图34a,通过RT-qPCR,与CSC相关的转录因子(CSC-TF:Sox2,Nanog,Oct3 / 4)和与EMT相关的TF(EMT-TF:Twist,Snail1,Snail2)。流式细胞仪用于定量和富集ALDH + CSC。使用miR?34a模拟物的转染来评估其对CSC标记图谱以及HNSCC-SDC中CSC-和EMT-TFs表达的调控潜力。分别通过基质胶侵袭,克隆形成性和球体形成测定法评估分选ALDH +和ALDH-细胞后,miR?34a模拟转染SDC的侵袭,集落形成和克隆形成能力。与亲本MDC相比,大多数源自HNSCC系的SDC中的miR?34a表达水平明显下调(-1.6-16.4倍)。对于EMT和CSC相关的TF表达,与亲本MDC相比,所有HNSCC衍生的SDC均显示出显着增加的水平(≤36.8倍)。在SDC中发现ALDH的表达显着增加(2-3倍)。与HPV +相比,HPV-组的EMT-TFs,CSCs-TFs和ALDH的平均表达水平明显更高(30.3 vs. 12.8%)。 miR?34a模拟物的转染显着降低了UM-SCC9(HPV-)和UM-SCC47(HPV +)SDC中与EMT和CSC相关的TF表达水平。同时,与对照相比,miRα34a模拟物的转染也显着降低了ALDH的表达(1.5-2倍),侵袭能力(≤30%)和HNSCC-SDC的克隆形成能力也受到抑制。 miRα34a的恢复显着抑制了HNSCC细胞系中EMT形成CSC表型的能力,并在功能上降低了克隆形成和侵袭能力。 HNSCC和CSC中miR?34a的治疗性调节可降低治疗后肿瘤的转移和复发率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号